Related by context. Frequent words. (Click for all words.) 68 safety tolerability pharmacokinetics 62 tolerated dose MTD 61 safety tolerability 60 pharmacokinetic profile 59 pharmacodynamics 59 label dose escalation 59 SCH # 57 rNAPc2 56 investigational oral 55 Phase 1b trial 54 IMC A# 54 active comparator 54 orally bioavailable 54 dose escalation trial 54 pharmacodynamic 53 pharmacokinetics 53 dose escalation study 53 6R BH4 53 selective inhibitor 53 plus prednisone 53 HGS ETR1 53 tolerability 53 single ascending dose 52 dose limiting toxicities 52 immunomodulator 52 Phase 1b 52 Synavive 52 PXD# 52 PEG Interferon lambda 52 blinded placebo controlled 51 Gravatar enabled weblog 51 placebo controlled randomized 51 randomized Phase III 51 dosing regimens 51 Vilazodone 51 NGX# 51 humanized anti 51 CA4P 50 multicenter randomized 50 intravenously administered 50 Phase 2a trial 50 antiviral activity 50 dose regimens 50 LY# [003] 50 Empatic 50 receptor antagonists 50 limiting toxicity 50 widgetised area 50 Phase Ib 50 Phase IIa clinical 50 imetelstat 50 CRx 50 CYT# 50 phase IIa 49 efficacy 49 blind randomized placebo 49 tezampanel 49 Tolerability 49 radiolabeled 49 PRX # 49 Secondary endpoints included 49 PS# [001] 49 DB# [003] 49 LEVADEX 49 Phase IIa trial 49 multicenter randomized double 49 antitumor activity 49 CK # 49 teduglutide 49 xenograft models 49 prodrug 49 Phase 1b clinical 49 ATTRACT 49 rHuPH# 49 multiple ascending dose 48 BAY #-# 48 diabetic neuropathic pain 48 mcg kg 48 Phase Ia 48 PLEASE NOTE Commenting 48 investigational drug 48 NU# [001] 48 CoFactor 48 phase IIb 48 Secondary endpoints include 48 eculizumab 48 HDAC inhibitor 48 seliciclib 48 ISIS # 48 Phase IIa 48 interferon alfa 48 immunogenicity 48 Phase 1a 48 GRN#L 48 TRIOLEX 47 vicriviroc 47 axitinib 47 kinase inhibitor 47 Ostarine 47 phase 2a 47 CTCE